Queensland COVID-19 Vaccination Safety and Efficacy Trial (QoVAX SET)
April 12, 2022
The QoVAX SET Statewide Study aims to better understand the short, medium and long-term impacts of COVID-19 and COVID-19 vaccines in Queensland. This includes understanding how and why people’s immune systems respond differently to COVID-19 vaccines.
This study will help health services to make decisions about ongoing vaccine programs and to plan for more people needing treatment for the COVID-19 virus. The Queensland Health program team are looking for participants to take part in the study.
Eligible participants are people who:
- have had at least two doses of a COVID-19 vaccine with the last dose received one to three months ago
- are 18 years old or over and a Queensland resident.
Participants will need to complete a survey and may be asked to provide a blood sample. If you have any questions, contact the QoVAX SET Program Team at QoVAX-Statewide@health.qld.gov.au or call 07 3647 1064.